P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,149.35
61.45 (1.01%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 26.06 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
641.76
21.90
3.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
641.76
21.90
3.41%
Raw Material Cost
137.67
394.86
-257.19
-65.13%
Purchase of Finished goods
34.95
0.00
34.95
(Increase) / Decrease In Stocks
-10.23
-8.82
-1.41
-15.99%
Employee Cost
109.89
105.32
4.57
4.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
89.40
91.37
102.20%
Total Expenditure (Excl Depreciation)
453.05
580.76
-127.71
-21.99%
Operating Profit (PBDIT) excl Other Income
210.61
61.00
149.61
245.26%
Other Income
8.98
55.63
-46.65
-83.86%
Operating Profit (PBDIT)
219.59
116.63
102.96
88.28%
Interest
0.24
4.99
-4.75
-95.19%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
111.64
107.71
96.48%
Depreciation
11.52
20.94
-9.42
-44.99%
Profit Before Tax
207.83
90.71
117.12
129.11%
Tax
53.11
22.38
30.73
137.31%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
68.33
86.39
126.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
68.33
86.39
126.43%
Equity Capital
16.60
30.62
-14.02
-45.79%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
4.46
88.74
1,989.69%
Diluted Earnings per share
93.21
4.46
88.75
1,989.91%
Operating Profit Margin (Excl OI)
31.73%
9.51%
0.00
22.22%
Gross Profit Margin
33.05%
17.40%
0.00
15.65%
PAT Margin
23.31%
10.65%
0.00
12.66%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024